Revised Medicare Fee Schedule Will Impact Endocrinologists

On December 1, 2020, the Centers for Medicare & Medicaid Services (CMS) released the Medicare Physician Fee Schedule (MPFS) final rule for CY 2021.

This rule updates payment policies and payment rates for Part B services furnished under the MPFS, as well as makes changes to the Quality Payment Program.

As a result of changes included in the rule, endocrinologists are expected to see a 13% increase in Medicare reimbursement while other specialties faced significant cuts. However, in an unusual move, Congress revised provisions of the Medicare regulation in its final year-end legislation to mitigate the cuts for some specialties.

Congress revised provisions of the Medicare regulation in its final year-end legislation to mitigate the cuts for some specialties.

Consequently, funding for the add-on complexity code for office E&M that would have been applied to essentially all endocrinology visits was removed and will reduce the amount of the previously predicted increase in total Medicare reimbursements for endocrinologists.

The Society has provided additional information on this reimbursement change at: www.endocrine.org/improving-practice/macra.

You may also like

  • 2020 Hindsight: The Endocrine Society’s Unforgettable Year

    As 2020 winds down, Endocrine News is taking a quick jaunt down memory lane to focus on the many accomplishments the Endocrine Society had over the course of the last 12 months. Despite various obstacles and upended plans, 2020 turned out to be a remarkable year for progress and successful new endeavors. We were somewhere…

  • Endocrine Society Researcher Hill Day Advocates for More NIH Funding, Special Diabetes Reauthorization

    On March 10, a small but mighty group of Endocrine Society members came to Washington D.C., to meet with their congressional delegations. Despite a number of other priorities requiring the attention of Congress, the federal appropriations process for FY 2021 must move forward and this is the time to influence decisions about funding. We used…

Find more in